Status:

COMPLETED

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

Lead Sponsor:

The University of Texas Medical Branch, Galveston

Collaborating Sponsors:

The Moody Foundation

Conditions:

Growth Hormone Deficiency

Traumatic Brain Injury

Eligibility:

All Genders

21+ years

Phase:

PHASE4

Brief Summary

Fifteen to twenty percent of adults who suffer a traumatic brain injury (TBI) that requires hospitalization and rehabilitation have been found to have growth hormone (GH) deficiency by GH stimulation ...

Detailed Description

This protocol is designed to screen and detect evidence of pituitary hormone deficiency in adults following traumatic brain injury. Growth hormone deficiency will be replaced for a period of one year....

Eligibility Criteria

Inclusion

  • Patients aged 21 and older.
  • Documented moderate to severe traumatic brain injury at least one year post injury.

Exclusion

  • The only absolute exclusionary medication will be an anticoagulant (Coumadin) because of the risk of bleeding during the possible muscle biopsy procedure and daily injections of rhGH in the GH arm of the study.
  • Any subject with a history of hepatitis or a 3-fold elevation of liver function tests (Alk phos, alanine aminotransferase (ALT), aspartate aminotransferase (AST)). We are uncertain of the effects of hormone replacement such as rhGH on the liver, so we will exclude any subjects with hepatitis. This exclusion applies only to subjects who would be enrolled in the GH arm of the study.
  • Subjects who are deficient in cortisol or thyroid at screening will be excluded until hormone abnormalities have been corrected.
  • Subjects with chronic pain who are being managed with narcotics will be excluded as the effects of central nervous system depressants may interfere with study test results.

Key Trial Info

Start Date :

November 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00957671

Start Date

November 1 2003

End Date

October 1 2015

Last Update

June 29 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Transitional Learning Center

Galveston, Texas, United States, 77550

2

The University of Texas Medical Branch at Galveston

Galveston, Texas, United States, 77555